SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003605
Filing Date
2019-04-30
Accepted
2019-04-30 16:01:55
Documents
75
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20190331x10q.htm 10-Q 1914022
2 EX-10.1 vvus-20190331ex10149a972.htm EX-10.1 31563
3 EX-31.1 vvus-20190331ex311c67b54.htm EX-31.1 19940
4 EX-31.2 vvus-20190331ex31268a43b.htm EX-31.2 19578
5 EX-32 vvus-20190331xex32.htm EX-32 16815
  Complete submission text file 0001558370-19-003605.txt   6935880

Data Files

Seq Description Document Type Size
6 EX-101.INS vvus-20190331.xml EX-101.INS 1449397
7 EX-101.SCH vvus-20190331.xsd EX-101.SCH 42990
8 EX-101.CAL vvus-20190331_cal.xml EX-101.CAL 70788
9 EX-101.DEF vvus-20190331_def.xml EX-101.DEF 163295
10 EX-101.LAB vvus-20190331_lab.xml EX-101.LAB 399886
11 EX-101.PRE vvus-20190331_pre.xml EX-101.PRE 327812
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 19781549
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1